Table 2: Study endpoints.

EndpointSitagliptin  
( )
Placebo  
( )
value

Mean blood glucose control (mg/dL)
 Overall 4-day study period147.29 ± 4.79153.0 ± 4.610.388
 SD no. 1160.5 ± 33.0150.5 ± 28.5
 SD no. 2163.1 ± 37.9164.3 ± 33.9
 SD no. 3137.4 ± 25.1149.7 ± 30.6
 SD no. 4128.2 ± 21.7147.7 ± 34.5

SD: study day.